Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
Applied DNA Sciences (NASDAQ:APDN) has been awarded a subcontract by LRQA for a pilot isotopic testing program in Pakistan. The project, part of the Global Trace Protocol initiative, aims to reduce child and forced labor in global supply chains through traceability. Applied DNA will use its CertainT platform, which employs isotope testing, DNA tagging, and genomic testing for cotton textile traceability.
The project is funded by the U.S. Department of Labor with a total of $4 million in federal funds. Applied DNA will work with Isotech to conduct isotopic analysis of raw materials and products at key points in the cotton textile value chain. This initiative aligns with new import regulations requiring verification of cotton origin to ensure it doesn't come from high-risk sources.
Applied DNA Sciences (NASDAQ:APDN) ha ricevuto un subappalto da LRQA per un programma pilota di test isotopici in Pakistan. Il progetto, parte dell'iniziativa Global Trace Protocol, ha l'obiettivo di ridurre il lavoro minorile e forzato nelle catene di supply globali attraverso la tracciabilità. Applied DNA utilizzerà la sua piattaforma CertainT, che impiega test isotopici, etichettatura del DNA e test genomici per la tracciabilità del cotone tessile.
Il progetto è finanziato dal Dipartimento del Lavoro degli Stati Uniti con un totale di 4 milioni di dollari in fondi federali. Applied DNA collaborerà con Isotech per condurre analisi isotopiche delle materie prime e dei prodotti in punti chiave della filiera del cotone tessile. Questa iniziativa è in linea con le nuove normative sulle importazioni che richiedono la verifica dell'origine del cotone per assicurarsi che non provenga da fonti ad alto rischio.
Applied DNA Sciences (NASDAQ:APDN) ha recibido un subcontrato de LRQA para un programa piloto de pruebas isotópicas en Pakistán. El proyecto, parte de la iniciativa Global Trace Protocol, tiene como objetivo reducir el trabajo infantil y forzado en las cadenas de suministro globales a través de la trazabilidad. Applied DNA utilizará su plataforma CertainT, que emplea pruebas isotópicas, etiquetado de ADN y pruebas genómicas para la trazabilidad del textil de algodón.
El proyecto está financiado por el Departamento de Trabajo de EE.UU. con un total de 4 millones de dólares en fondos federales. Applied DNA trabajará con Isotech para llevar a cabo análisis isotópicos de materias primas y productos en puntos clave de la cadena de valor del textil de algodón. Esta iniciativa está alineada con las nuevas regulaciones de importación que exigen la verificación del origen del algodón para asegurar que no provenga de fuentes de alto riesgo.
Applied DNA Sciences (NASDAQ:APDN)는 파키스탄에서 LRQA로부터 파일럿 동위원소 테스트 프로그램의 하청 계약을 체결했습니다. 이 프로젝트는 Global Trace Protocol 이니셔티브의 일환으로, 글로벌 공급망에서 아동 및 강제 노동을 줄이는 것을 목표로 합니다. Applied DNA는 동위원소 테스트, DNA 태깅, 유전자 검사를 사용하여 면직물의 추적 가능성을 위해 CertainT 플랫폼을 사용할 것입니다.
이 프로젝트는 미국 노동부에서 지원하는 기금으로 총 400만 달러의 연방 자금이 지원됩니다. Applied DNA는 면직물 가치 사슬의 주요 지점에서 원자재 및 제품의 동위원소 분석을 수행하기 위해 Isotech과 협력할 것입니다. 이 이니셔티브는 면화 원산지 확인을 요구하는 새로운 수입 규정과 일치하여, 고위험 출처에서 오지 않도록 보장합니다.
Applied DNA Sciences (NASDAQ:APDN) a reçu un sous-traité de LRQA pour un programme pilote de tests isotopiques au Pakistan. Ce projet fait partie de l'initiative Global Trace Protocol, visant à réduire le travail des enfants et le travail forcé dans les chaînes d'approvisionnement mondiales par le biais de la traçabilité. Applied DNA utilisera sa plateforme CertainT, qui emploie des tests isotopiques, du marquage ADN et des tests génomiques pour la traçabilité des textiles en coton.
Le projet est financé par le Département du Travail des États-Unis avec un total de 4 millions de dollars en fonds fédéraux. Applied DNA travaillera avec Isotech pour effectuer des analyses isotopiques des matières premières et des produits à des points clés de la chaîne de valeur du textile en coton. Cette initiative est en accord avec les nouvelles réglementations sur les importations exigeant la vérification de l'origine du coton afin de s'assurer qu'il ne provienne pas de sources à haut risque.
Applied DNA Sciences (NASDAQ:APDN) hat einen Subvertrag von LRQA für ein pilot-isotopisches Testprogramm in Pakistan erhalten. Das Projekt ist Teil der Global Trace Protocol-Initiative und soll Kinder- und Zwangsarbeit in globalen Lieferketten reduzieren durch Rückverfolgbarkeit. Applied DNA wird seine CertainT-Plattform nutzen, die Isotopentests, DNA-Tagging und genomische Tests für die Rückverfolgbarkeit von Baumwolltextilien einsetzt.
Das Projekt wird vom US-Arbeitsministerium finanziert und erhält insgesamt 4 Millionen Dollar an Bundesmitteln. Applied DNA wird mit Isotech zusammenarbeiten, um isotopische Analysen von Rohstoffen und Produkten an wichtigen Stellen der Baumwolltextilwertschöpfungskette durchzuführen. Diese Initiative steht im Einklang mit neuen Einfuhrvorschriften, die eine Verifizierung des Baumwollursprungs erfordern, um sicherzustellen, dass sie nicht aus Hochrisikogebieten stammt.
- Awarded subcontract for isotopic testing pilot program in Pakistan
- CertainT platform selected for cotton traceability project
- Collaboration with LRQA on U.S. Department of Labor-funded initiative
- Potential for increased business in cotton authentication technologies
- Financial terms of the subcontract not disclosed
This pilot project marks a strategic move for Applied DNA Sciences (NASDAQ:APDN) in the growing market for supply chain traceability. The collaboration with LRQA on the Global Trace Protocol project positions Applied DNA at the forefront of addressing critical issues in the textile industry, particularly concerning child and forced labor.
The use of Applied DNA's CertainT® platform for isotopic testing demonstrates the company's technological edge in forensic authentication. This could lead to increased adoption of their solutions, especially given the new import regulations requiring verification of cotton origin. The project's alignment with U.S. Department of Labor initiatives and
While financial terms weren't disclosed, this pilot could open doors to larger contracts and partnerships in the future, potentially boosting Applied DNA's market position and revenues in the long term. Investors should monitor the project's outcomes and any subsequent expansions of Applied DNA's role in global supply chain verification.
Applied DNA's CertainT® platform showcases an innovative approach to supply chain traceability. By combining isotope testing, DNA tagging and genomic testing, the company offers a multi-layered authentication system that's hard to replicate or falsify.
The use of Isotope Ratio Mass Spectrometry (IRMS) is particularly noteworthy. This technology can pinpoint the geographical origin of materials by analyzing their isotopic composition, which varies based on factors like soil and climate. When coupled with DNA tagging, it creates a robust verification system that can track cotton from farm to finished product.
The scalability mentioned in the Indus Apparel project suggests that Applied DNA has solved implementation challenges often associated with such technologies. This could be a significant competitive advantage as demand for traceability solutions grows. The company's ability to adapt its technology to meet specific regulatory requirements also positions it well for future market expansion.
- Pilot Project To Demonstrate Effectiveness of CertainT® for Cotton Textile Traceability -
STONY BROOK, NY / ACCESSWIRE / September 4, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the receipt of a subcontract award from LRQA following a competitive tender for a pilot isotopic testing program. Under the terms of the subcontract, Applied DNA, together with its traceability partner, Isotech (a Stratum Reservoir company), will employ CertainT® to conduct isotopic testing and analysis to support cotton traceability in Pakistan. Financial terms of the subcontract were not disclosed.
CertainT is Applied DNA's textiles traceability platform that uses forensic, multiple-proof-point evidence to enable source and authenticity verification of materials and products at any point as they are transformed through global supply chains. LRQA is a leading global assurance company that brings together decades of unrivaled expertise in assessment, advisory, inspection, and cybersecurity services.
The subcontract with Applied DNA was issued in support of the Global Trace Protocol project (the "Project"), a U.S. Department of Labor-funded initiative implemented by LRQA (known as ELEVATE during the Project's inception) that is designed to reduce child and forced labor in global supply chains through traceability. The Project engages with trace experts, global brands, Pakistan's cotton sector, and worker organizations to design, implement, and assess the pilot trace tool to improve its future application and develop publicly available commodity-agnostic trace resources for enhanced due diligence.
Jeff Wheeler, Director of the Global Trace Protocol project at LRQA, stated, "New import regulations and legislation now require extra documentation to verify cotton origin and ensure that cotton does not come from high-risk sources. The Global Trace Protocol project is developing traceability technology tools that provide greater transparency and integrity to textile value chains globally, including through our work with Applied DNA."
Applied DNA and Isotech will utilize best practices in the isotopic analysis of raw materials and products at key points in the cotton textile value chain, aligning with the Project's overarching goals. Some of the testing components include the use of isotope ratio mass spectrometry (IRMS) on samples from farms, gins, yarn spinners, and mills/manufacturing units identified by the Project. CertainT will establish a baseline as part of the pilot Project of the framework for isotope testing and analyses.
MeiLin Wan, Vice President of Textiles at Applied DNA, said, "Our CertainT platform employs isotope testing as well as DNA tagging and genomic testing as forensic authentication technologies to establish traceability to prove origin. Our recent announcement with Indus Apparel of isotope testing with DNA tagging showcases the scalability and accessibility of cotton authentication technologies that will also help Pakistan's cotton industry to enable compliance with U.S. import regulations and similar enforcement in other geographies."
Global Trace Protocol Project Funding
Funding for the Global Trace Protocol project is provided by the United States Department of Labor under cooperative agreement number IL-35808-20-75-K-. 100 percent of the total costs of the Global Trace Protocol project is financed with federal funds, for a total of USD 4,000,000*.
The isotopic testing pilot project contract is awarded to Applied DNA through a subcontract from LRQA in support of the Global Trace Protocol project.
*This announcement does not necessarily reflect the views or policies of the United States Department of Labor, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.
About the CertainT® Platform
The CertainT® platform is a multi-proof point technology system that consists of isotope testing together with DNA tagging and genomic testing to enable secure supply chain traceability, transparency, and trust. The platform is grounded in over 15 years of Applied DNA's expertise in the development of cotton-based diagnostic testing to verify the origin and authenticity of cotton. Under CertainT®, isotope testing is provided in collaboration with "Stratum Reservoir (Isotech), LLC, a Stratum Reservoir company" as the largest commercial isotope laboratory in the U.S., providing services to the oil and gas, food, and textiles industries, to name a few.
About LRQA
LRQA is the leading global assurance partner, bringing together decades of unrivalled expertise in assessment, advisory, inspection and cybersecurity services. LRQA's solutions-based partnerships are supported by data-driven insights that help our clients solve their biggest business challenges.
Operating in more than 150 countries with a team of more than 5,000 people, LRQA's award-winning compliance, supply chain, cybersecurity and ESG specialists help more than 61,000 clients across almost every sector to anticipate, mitigate and manage risk wherever they operate.
Through all its efforts, LRQA is committed to shaping a better future for people, clients, communities and planet.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, through our recent acquisition of Spindle Biotech, Inc. ("Spindle"), the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be "forward-looking" in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to its history of net losses, limited financial resources, unknown future demand for its CertainT® platform, the limited market acceptance for its CertainT Platform, the unknown future impact of the UFLPA on the demand for the CertainT platform, and various other factors detailed from time to time in Applied DNA's SEC reports and filings, including its Annual Report on Form 10-K, as amended, filed on December 7, 2023, and Quarterly Report on Form 10-Q filed on February 8, 2024, May 10, 2024, and August 8, 2024, other reports it files with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.
Contacts:
LRQA:
Contact: Jeffrey Wheeler, jeffrey.wheeler@lrqa.com
LinkedIn: LRQA | LRQA Sustainability
APPLIED DNA:
Program contact: MeiLin Wan, meilin.wan@adnas.com
Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
X: @APDN
LinkedIn: Applied DNA | CertainT®
Web: www.adnas.com | www.certaint.com
SOURCE: Applied DNA Sciences
View the original press release on accesswire.com
FAQ
What is the purpose of the isotopic testing pilot project awarded to Applied DNA (APDN)?
How much funding has been allocated for the Global Trace Protocol project involving Applied DNA (APDN)?
What technologies does Applied DNA (APDN) use in its CertainT platform for cotton traceability?
Why is cotton traceability important in the context of this project involving Applied DNA (APDN)?
